|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aziyo Biologics, Inc. (AZYO) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
7,090,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aziyo Biologics is a commercial-stage regenerative medicine company. Co.'s Core Products include: CanGaroo, which is a biological envelope that remodels into systemically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke and VasCure, which are portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. Co.'s Non-Core Products include the contract manufacturing of particulate bone, milled bone, cellular bone matrix, acellular dermis, amnion and other soft tissue products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,005,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,241,028 |
| Total People Bought |
0 |
0 |
0 |
5 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
289 |
| Total Sell Value |
$0 |
$0 |
$0 |
$1,243 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ferguson Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-08 |
4 |
D |
$7.30 |
$35,025 |
D/D |
(4,798) |
17,217 |
|
- |
|
| Ferguson Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,874 |
22,015 |
|
- |
|
| Englese Thomas |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-09-08 |
4 |
D |
$7.30 |
$34,514 |
D/D |
(4,728) |
17,269 |
|
- |
|
| Englese Thomas |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,390 |
21,997 |
|
- |
|
| Riebman Jerome |
CHIEF MEDICAL OFFICER |
• – – |
2022-09-08 |
4 |
D |
$7.30 |
$37,259 |
D/D |
(5,104) |
14,989 |
|
- |
|
| Riebman Jerome |
CHIEF MEDICAL OFFICER |
• – – |
2022-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,758 |
20,093 |
|
- |
|
| Edwards Peter G |
GENERAL COUNSEL |
• – – |
2022-09-08 |
4 |
D |
$7.30 |
$8,227 |
D/D |
(1,127) |
3,498 |
|
- |
|
| Edwards Peter G |
GENERAL COUNSEL |
• – – |
2022-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,625 |
4,625 |
|
- |
|
| Strobeck Matthew |
10% Owner |
– – • |
2022-05-11 |
4 |
B |
$5.96 |
$1,192 |
I/I |
200 |
1,418,123 |
1.42 |
- |
|
| Englese Thomas |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-03-10 |
4 |
S |
$0.00 |
$0 |
D/D |
(276) |
6,607 |
|
- |
|
| Roberts Darryl |
EVP, OPERATIONS & PRODUCT DEV. |
• – – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
938 |
3,329 |
|
- |
|
| Englese Thomas |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
938 |
6,883 |
|
- |
|
| Ferguson Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,288 |
8,140 |
|
- |
|
| Riebman Jerome |
CHIEF MEDICAL OFFICER |
• – – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
782 |
5,334 |
|
- |
|
| Lloyd Ronald K. |
PRESIDENT AND CEO |
• • – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,072 |
31,775 |
|
- |
|
| Englese Thomas |
CHIEF COMMERCIAL OFFICER |
• – – |
2021-12-14 |
4 |
B |
$6.10 |
$27,938 |
D/D |
4,580 |
5,088 |
0.01 |
- |
|
| Rakin Kevin |
Director |
– • • |
2021-12-08 |
4 |
B |
$4.24 |
$1,749,996 |
I/I |
412,735 |
90,807 |
2.25 |
- |
|
| Strobeck Matthew |
10% Owner |
– – • |
2021-12-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,417,923 |
|
- |
|
| Highcape Partners Gp Ii, L.p. |
10% Owner |
– – • |
2021-09-21 |
4 |
B |
$0.00 |
$0 |
I/I |
2,837,128 |
8,434,732 |
1.42 |
- |
|
| Highcape Co-Investment Vehicle Ii, Llc |
10% Owner |
– – • |
2021-09-21 |
4 |
B |
$0.00 |
$0 |
I/I |
2,837,128 |
8,434,732 |
1.42 |
- |
|
| Ferguson Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2021-05-11 |
4 |
B |
$11.00 |
$11,000 |
D/D |
1,000 |
2,300 |
2.74 |
- |
|
| Ferguson Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2021-05-10 |
4 |
B |
$11.14 |
$14,482 |
D/D |
1,300 |
1,300 |
2.74 |
- |
|
| Lloyd Ronald K. |
PRESIDENT AND CEO |
• • – |
2021-05-07 |
4 |
B |
$11.65 |
$100,643 |
D/D |
8,565 |
23,151 |
2.81 |
- |
|
| Lloyd Ronald K. |
President and CEO |
• • – |
2020-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
14,586 |
14,586 |
|
- |
|
| Rakin Kevin |
Director |
– • • |
2020-10-13 |
4 |
B |
$17.00 |
$7,499,992 |
I/I |
441,176 |
4,508,831 |
2.25 |
- |
|
56 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
